Related Experiment Video

Updated: May 6, 2026

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

13.2K

[Genetic risk factors for vasculitis]

J U Holle1, W L Gross

  • 1Klinik für Rheumatologie und Immunologie, Klinikum Bad Bramstedt, Oskar-Alexander-Str. 26, 24576, Bad Bramstedt, Deutschland, j.holle@klinikumbb.de.

Der Internist
|November 13, 2013
PubMed

Insights

Genome-wide association studies reveal key genetic risk factors for vasculitis, including Behçet's disease and ANCA-associated vasculitis like GPA. Findings highlight specific gene polymorphisms influencing disease pathogenesis and potential therapeutic targets.

Area of Science:

  • Genetics
  • Immunology
  • Rheumatology

Context:

  • Genome-wide association studies (GWAS) are crucial for understanding complex diseases.
  • Vasculitis encompasses a group of autoimmune disorders characterized by inflammation of blood vessels.
  • Previous GWAS have identified genetic predispositions for Behçet's disease, Kawasaki disease, granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA).

Purpose:

  • To summarize the findings of GWAS in vasculitis, focusing on genetic risk factors.
  • To identify specific genes and polymorphisms associated with Behçet's disease and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
  • To provide insights into the pathogenesis and potential therapeutic targets for these conditions.

Summary:

  • GWAS for Behçet's disease identified risk factors including HLA-B51, HLA-A26, IL-10, IL-12R/IL-23R, STAT4, and ERAP-1.
  • GWAS for ANCA-associated vasculitis (GPA and MPA) confirmed HLA-DP as a major risk locus for GPA.
  • Genetic risk factors for GPA include SERPINA-1 (α-1-antitrypsin deficiency) and polymorphisms in the proteinase 3 (PR3) gene, a target antigen in PR3-ANCA vasculitis.

Impact:

  • These genetic insights enhance our understanding of vasculitis pathogenesis.
  • Identification of specific genetic risk factors can inform diagnostic strategies and risk stratification.
  • The findings may pave the way for novel targeted therapies for vasculitis patients.

More Related Videos

On-Chip Endothelial Inflammatory Phenotyping12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

10.4K
Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

18.5K

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
143
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
248
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.7K